Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic sitagliptin (MEDIGLIPTIN 100 mg) vs JANUVIA in healthy Thai volunteers under fasting
TCTR20211220005Phase 4Not yet recruiting
- Sponsor
- Medic Pharma
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin, sponsored by Medic Pharma. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
sitagliptin
Beyond the preview
Go deeper on TCTR20211220005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211220005.